Our research aims at inventing the next generation of molecular probes to visualize, understand and treat diseases.
We develop innovative molecular imaging agents spanning fluorescence-guided surgery, multimodal imaging and theranostics, with a particular focus on near-infrared (NIR-I and NIR-II/SWIR) fluorophores, such as WazaBYs (Water-soluble aza-BODIPY). Beyond fluorophore design, we engineer multifunctional molecular platforms that combine optical imaging, radionuclide imaging, targeted delivery and therapeutic functionalities within a single construct.
Our work encompasses molecular design, synthetic chemistry, photophysical characterization, bioconjugation, radiochemistry and preclinical evaluation in close collaboration with clinicians and imaging specialists.
By bridging chemistry, imaging sciences and medicine, we aim to accelerate the translation of next-generation probes toward clinical applications.